In summary, I-FABP is a valid serologic biomarker for early diagnosis of NEC for the premature neonates with a moderate accuracy; thus it may serve as a new auxiliary diagnosis method and decrease the omission diagnostic rate. The gene discussed is FABP2; the disease is necrotizing enterocolitis.